4.4 Article

The Prevalence of FOXP3+ Regulatory T-Cells in Peripheral Blood of Patients with NSCLC

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2008

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2008)

Review Medicine, General & Internal

Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship

Julian R. Molina et al.

MAYO CLINIC PROCEEDINGS (2008)

Review Immunology

Regulatory T cells, tumour immunity and immunotherapy

WP Zou

NATURE REVIEWS IMMUNOLOGY (2006)

Article Multidisciplinary Sciences

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts

H Nishikawa et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Immunology

Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia

CR Ruprecht et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Review Immunology

Cancer vaccines: Between the idea and the reality

OJ Finn

NATURE REVIEWS IMMUNOLOGY (2003)

Article Multidisciplinary Sciences

Control of regulatory T cell development by the transcription factor Foxp3

S Hori et al.

SCIENCE (2003)

Article Medicine, General & Internal

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

L Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)

Article Immunology

CD4+CD25high regulatory cells in human peripheral blood

C Baecher-Allan et al.

JOURNAL OF IMMUNOLOGY (2001)

Review Biochemistry & Molecular Biology

Regulatory T cells: Key controllers of immunologic self-tolerance

S Sakaguchi